Cited by 304Gut microbiota and healthInflammatory Bowel DiseaseClostridium difficile and Clostridium perfringens research

Decreased abundance of F aecalibacterium prausnitzii in the gut microbiota of C rohn's disease

Fujimoto, Takehide, Imaeda, Hirotsugu, Takahashi, Kenichiro, Kasumi, Eiji, Bamba, Shigeki, Fujiyama, Yoshihide, Andoh, Akira·2013·Journal of Gastroenterology and Hepatology

Abstract

Background and Aims: Dysbiosis is thought to be relevant to the etiology and pathogenesis of C rohn's disease ( CD ). In this study, we investigated the abundance of F aecalibacterium prausnitzii , as well as B ilophila wadsworthia , in the gut microbiota of J apanese CD patients. Methods: Forty‐seven CD patients and 20 healthy controls were enrolled. Abundance of F . prausnitzii in fecal samples was quantified by real‐time polymerase chain reaction. The gut microbiota profile was evaluated by terminal restriction fragment length polymorphisms. Results: The abundance of F . prausnitzii significantly decreased in CD patients compared with healthy subjects. B . wadsworthia was scarcely detected in the same samples. Among CD patients, the C rohn's D isease A ctivity I ndex, C ‐reactive protein levels, and erythrocyte sedimentation rate were significantly lower, and serum albumin levels were significantly higher in the high F . prausnitzii group compared with the low group. Terminal restriction fragment length polymorphisms analysis showed that fecal bacterial communities of CD patients differed from those of healthy individuals. The changes in simulated bacterial composition indicated that class C lostridia, including genus F aecalibacterium, was significantly less abundant in CD patients as compared with healthy individuals. The bacterial diversity measured by the S hannon D iversity I ndex was significantly reduced in CD patients compared with healthy individuals. Conclusion: The decreased abundance of class C lostridia, including F . prausnitzii , may translate into a reduction of commensal bacteria‐mediated, anti‐inflammatory activities in the mucosa, which are relevant to the pathophysiology of CD . In contrast, the role of B . wadsworthia was suspected to be minimal.

Integrity signals

Registry

Crossref · 10.1111/jgh.12073

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Saccharolytic organisms such as Ruminococcaceae and Lachnospiraceae persist in fibrolytic gut communities and are considered an important component of a healthy gut microbiota, while their depletion has been observed in inflammatory bowel disease patients.

    “These saccharolytic organisms persist in fibrolytic gut communities and are considered an important component of a healthy gut microbiota, while their depletion has been observed in inflammatory bowel disease patients [189, 190].”

    From The athletic gut microbiota (2020) · cites this paper as [190]

  • Faecalibacterium prausnitzii is depleted in IBD patients, including ulcerative colitis.

    “The depletion of F prausnitzii in IBD patients3,41,42, including ulcerative colitis43”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fujimoto, T., Imaeda, H., Takahashi, K., Kasumi, E., Bamba, S., Fujiyama, Y., & Andoh, A.
Affiliations
  • Division of Mucosal Immunology Graduate School
  • Shiga University of Medical Science (JP)
Corresponding author
Andoh, Akira
Venue
Journal of Gastroenterology and Hepatology
Publisher
Wiley
Published
2013-03-25
Volume
28
Issue
4
Pages
613-619
ISSN
  • 0815-9319 (ISSN-L)
  • 1440-1746
OpenAlex
W1569647046
Cited by
304
References
45
Citations by year
2026: 12 · 2025: 23 · 2024: 25 · 2023: 25 · 2022: 30 · 2021: 25 · 2020: 20 · 2019: 31 · 2018: 24 · 2017: 20 · 2016: 20 · 2015: 19 · 2014: 14 · 2013: 15
FWCI
6.18
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Gastroenterology and Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Funders
TechnoSuruga Laboratory Co., Ltd.
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
Keywords
Crohn's disease, Faecalibacterium prausnitzii, gut microbiota, dysbiosis, Bilophila wadsworthia, Clostridia, bacterial diversity, CDAI, serum albumin, Japanese patients
MeSH terms
Adult, Clostridium, Crohn Disease, DNA, Bacterial, Feces, Female, Humans, Male, Middle Aged, Polymorphism, Restriction Fragment Length, Severity of Illness Index, Case-Control Studies, DNA Primers, Gastrointestinal Tract, Bilophila, Metagenome, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review